• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不断发展的胰腺癌外科肿瘤学知识:从理论到临床实践——在一家三级转诊中心的十五年历程。

Evolving knowledge in surgical oncology of pancreatic cancer: from theory to clinical practice-a fifteen-year journey at a tertiary referral centre.

机构信息

Division of Pancreatic Surgery, IRCCS, Azienda Ospedaliero Universitaria di Bologna, S.Orsola-Malpighi Hospital, Via Massarenti n.9, 40138, Bologna, Italy.

Department of Internal Medicine and Surgery (DIMEC), Alma Mater Studiorum, University of Bologna, S.Orsola-Malpighi Hospital, Bologna, Italy.

出版信息

Updates Surg. 2022 Oct;74(5):1533-1542. doi: 10.1007/s13304-022-01346-x. Epub 2022 Aug 25.

DOI:10.1007/s13304-022-01346-x
PMID:36008632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9481498/
Abstract

Pancreatic ductal adenocarcinoma (PDAC) is an increasing disease having a poor prognosis. The aim of the present study was to evaluate the effect of different models of care for pancreatic cancer in a tertiary referral centre in the period 2006-2020. Retrospective study of patients with PDAC observed from January 2006 to December 2020. The demographic and clinical data, and data regarding the imaging techniques used, preoperative staging, management, survival and multidisciplinary tumour board (MDTB) evaluation were collected and compared in three different periods characterised by different organisation of pancreatic cancer services: period A (2006-2010); period B (2011-2015) and period C (2016-2020). One thousand four hundred seven patients were analysed: 441(31.3%) in period A; 413 (29.4%) in B and 553 (39.3%) in C. The proportion of patients increased significantly, from 31.3% to 39.3% (P = 0.032). Body mass index (P = 0.033), comorbidity rate (P = 0.002) and Karnofsky performance status (P < 0.001) showed significant differences. Computed tomography scans (P < 0.001), endoscopic ultrasound (P < 0.001), fine needle aspiration, fine needle biopsy (P < 0.001), and fluorodeoxyglucose-positron emission tomography/computed tomography (P < 0.001) increased; contrast-enhanced ultrasound (P = 0.028) decreased. The cTNM was significantly different (P < 0.001). The MDTB evaluation increased significantly (P < 0.001). Up-front surgery and exploratory laparotomy decreased (P < 0.001), neoadjuvant treatment increased (P < 0.001). The present study showed the evolving knowledge in surgical oncology of pancreatic cancer at a tertiary referral centre over the time. The different models of care of pancreatic cancer, in particular the introduction of the MDTB and the institution of a pancreas unit to the decision-making process seemed to be influential.

摘要

胰腺导管腺癌 (PDAC) 是一种发病率不断增加的疾病,预后较差。本研究旨在评估 2006-2020 年期间在一家三级转诊中心对胰腺癌采用不同治疗模式的效果。对 2006 年 1 月至 2020 年 12 月期间观察到的 PDAC 患者进行回顾性研究。收集并比较了不同时期的人口统计学和临床数据,以及用于影像学技术、术前分期、管理、生存和多学科肿瘤委员会 (MDTB) 评估的数据,这些时期的特点是胰腺癌服务的组织方式不同:时期 A(2006-2010 年);时期 B(2011-2015 年)和时期 C(2016-2020 年)。共分析了 1407 例患者:时期 A 中 441 例(31.3%);B 中 413 例(29.4%);C 中 553 例(39.3%)。患者比例从 31.3%显著增加到 39.3%(P=0.032)。体重指数(P=0.033)、合并症发生率(P=0.002)和卡诺夫斯基表现状态(P<0.001)差异显著。计算机断层扫描(P<0.001)、内镜超声(P<0.001)、细针抽吸、细针活检(P<0.001)和氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(P<0.001)增加;增强超声(P=0.028)减少。cTNM 显著不同(P<0.001)。MDTB 评估显著增加(P<0.001)。直接手术和剖腹探查术减少(P<0.001),新辅助治疗增加(P<0.001)。本研究显示了三级转诊中心随时间推移在胰腺肿瘤外科治疗方面不断发展的知识。胰腺癌的不同治疗模式,特别是 MDTB 的引入和胰腺科室的建立对决策过程的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9513/9481498/17d378d7a110/13304_2022_1346_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9513/9481498/88ef4f83f6ad/13304_2022_1346_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9513/9481498/196cb9869ba6/13304_2022_1346_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9513/9481498/17d378d7a110/13304_2022_1346_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9513/9481498/88ef4f83f6ad/13304_2022_1346_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9513/9481498/196cb9869ba6/13304_2022_1346_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9513/9481498/17d378d7a110/13304_2022_1346_Fig3_HTML.jpg

相似文献

1
Evolving knowledge in surgical oncology of pancreatic cancer: from theory to clinical practice-a fifteen-year journey at a tertiary referral centre.不断发展的胰腺癌外科肿瘤学知识:从理论到临床实践——在一家三级转诊中心的十五年历程。
Updates Surg. 2022 Oct;74(5):1533-1542. doi: 10.1007/s13304-022-01346-x. Epub 2022 Aug 25.
2
Factors of Endoscopic Ultrasound-Guided Tissue Acquisition for Successful Next-Generation Sequencing in Pancreatic Ductal Adenocarcinoma.影响胰腺导管腺癌行超声内镜引导下组织获取用于下一代测序成功率的因素。
Gut Liver. 2020 May 15;14(3):387-394. doi: 10.5009/gnl19011.
3
[Value of endoscopic ultrasound-guided fine needle aspiration in pretest prediction and diagnosis of pancreatic ductal adenocarcinoma].[内镜超声引导下细针穿刺在胰腺导管腺癌术前预测及诊断中的价值]
Nan Fang Yi Ke Da Xue Xue Bao. 2018 Sep 30;38(10):1171-1178. doi: 10.3969/j.issn.1673-4254.2018.10.04.
4
Impact of calcifications on diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration for pancreatic ductal adenocarcinoma.钙化对内镜超声引导下细针穿刺活检诊断胰腺导管腺癌的影响
Indian J Gastroenterol. 2019 Apr;38(2):128-133. doi: 10.1007/s12664-019-00941-y. Epub 2019 Mar 22.
5
Prognostic influence of endoscopic ultrasound-guided fine needle aspiration in IPMN-derived invasive adenocarcinoma.内镜超声引导下细针抽吸对 IPMN 衍生浸润性腺癌的预后影响。
BMC Cancer. 2018 Oct 12;18(1):974. doi: 10.1186/s12885-018-4896-2.
6
A deep learning model to detect pancreatic ductal adenocarcinoma on endoscopic ultrasound-guided fine-needle biopsy.一种用于在内镜超声引导下细针活检中检测胰腺导管腺癌的深度学习模型。
Sci Rep. 2021 Apr 19;11(1):8454. doi: 10.1038/s41598-021-87748-0.
7
Pancreatic metastasis of papillary thyroid carcinoma preoperatively diagnosed by endoscopic ultrasound-guided fine-needle aspiration biopsy: a case report with review of literatures.经内镜超声引导下细针穿刺活检术前诊断甲状腺乳头状癌胰腺转移:1例病例报告并文献复习
Clin J Gastroenterol. 2018 Dec;11(6):521-529. doi: 10.1007/s12328-018-0875-z. Epub 2018 Jun 8.
8
EUS-guided reverse bevel fine-needle biopsy sampling and open tip fine-needle aspiration in solid pancreatic lesions - a prospective, comparative study.超声内镜引导下反向斜面细针活检采样及实心胰腺病变开放式细针抽吸术——一项前瞻性比较研究
Scand J Gastroenterol. 2018 Feb;53(2):231-237. doi: 10.1080/00365521.2017.1421704. Epub 2018 Jan 4.
9
Synchronous Pancreatic Ductal Adenocarcinomas Diagnosed by Endoscopic Ultrasound-Guided Fine Needle Biopsy.经内镜超声引导下细针穿刺活检诊断的同步性胰腺导管腺癌
Gut Liver. 2015 Sep 23;9(5):685-8. doi: 10.5009/gnl14215.
10
EUS - Fine- Needle Aspiration Biopsy (FNAB) in the Diagnosis of Pancreatic Adenocarcinoma: A Review.超声内镜引导下细针穿刺活检(FNAB)在胰腺腺癌诊断中的应用综述
Rom J Intern Med. 2016 Jan-Mar;54(1):24-30. doi: 10.1515/rjim-2016-0002.

引用本文的文献

1
Pancreatic Ductal Adenocarcinoma: Update of CT-Based Radiomics Applications in the Pre-Surgical Prediction of the Risk of Post-Operative Fistula, Resectability Status and Prognosis.胰腺导管腺癌:基于CT的影像组学在术前预测术后瘘风险、可切除性状态及预后方面的应用进展
J Clin Med. 2023 Nov 28;12(23):7380. doi: 10.3390/jcm12237380.

本文引用的文献

1
Long-term nationwide trends in the treatment of and outcomes among pancreatic cancer patients.胰腺癌患者治疗及预后的长期全国性趋势。
Eur J Surg Oncol. 2022 May;48(5):1087-1092. doi: 10.1016/j.ejso.2021.11.116. Epub 2021 Nov 19.
2
Pancreatic Cancer: A Review.胰腺癌:综述。
JAMA. 2021 Sep 7;326(9):851-862. doi: 10.1001/jama.2021.13027.
3
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.胰腺导管腺癌临床实践指南(第 2.2021 版),NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2021 Apr 1;19(4):439-457. doi: 10.6004/jnccn.2021.0017.
4
Trends in the treatment of pancreatic cancer in Japan.日本胰腺癌治疗趋势。
Biosci Trends. 2021 Jul 6;15(3):135-137. doi: 10.5582/bst.2021.01103. Epub 2021 Mar 26.
5
Pancreatoduodenectomy at the Verona Pancreas Institute: the Evolution of Indications, Surgical Techniques, and Outcomes: A Retrospective Analysis of 3000 Consecutive Cases.维罗纳胰腺研究所的胰十二指肠切除术:适应证演变、手术技术和结果:3000 例连续病例的回顾性分析。
Ann Surg. 2022 Dec 1;276(6):1029-1038. doi: 10.1097/SLA.0000000000004753. Epub 2021 Jan 15.
6
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
7
Bratislava Statement: consensus recommendations for improving pancreatic cancer care.布拉迪斯拉发声明:改善胰腺癌治疗的共识建议。
ESMO Open. 2020 Nov;5(6):e001051. doi: 10.1136/esmoopen-2020-001051.
8
Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma.全国范围内胰腺导管腺癌的发病率、治疗和生存趋势。
Eur J Cancer. 2020 Jan;125:83-93. doi: 10.1016/j.ejca.2019.11.002. Epub 2019 Dec 13.
9
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors.胰腺癌的流行病学:全球趋势、病因及风险因素
World J Oncol. 2019 Feb;10(1):10-27. doi: 10.14740/wjon1166. Epub 2019 Feb 26.
10
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.